Literature DB >> 8192155

Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman.

M Kumar1, P Mehta.   

Abstract

Pregnancy in women with congenital coagulation factor deficiencies has been associated with adverse fetal outcomes. Recurrent spontaneous abortions, placental abruptions, and premature births are reported, the exact reasons for which are not clear, and management of such patients continues to be a challenge. We reviewed the outcome of four pregnancies in a patient with factor X deficiency, and looked at the effect of factor replacement therapy on pregnancy. Her first two pregnancies resulted in the birth of extremely premature babies at 21 and 25 weeks of gestation, both of which died in the neonatal period. The patient was treated with fresh frozen plasma for acute bleeding episodes during these pregnancies. In addition during her second conception she was given factor IX complex [Konyne] prophylactically, but only in the latter half of her pregnancy. During her next two pregnancies she was treated early on during pregnancy, with prophylactic replacement of factor X. She delivered healthy babies at 34 and 32 weeks of gestation, and they are both doing well. We therefore suggest possible mechanisms by which aggressive prophylactic factor support in a female with severe congenital coagulopathy, may improve on fetal outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192155     DOI: 10.1002/ajh.2830460315

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy.

Authors:  Joost J van Veen; Kingsley K Hampton; Rhona Maclean; Fiona Fairlie; Michael Makris
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 2.  Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.

Authors:  Min Li; S Joseph Huang
Journal:  Thromb Res       Date:  2009-08-14       Impact factor: 3.944

3.  Factor X Deficiency Management for Elective Cesarean Delivery in a Pregnant Patient.

Authors:  Mirna Krkovic; Andrea Koosova Gajic; Janja Tarčuković; Vlatka Sotosek; Tea Stimac; Sanja Balen; Boban Dangubic; Igor Grubjesic
Journal:  Am J Case Rep       Date:  2020-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.